FAKTOR-OPTIONSSCHEIN - HALEON Share Price

Certificat

DE000MG0J133

Real-time Bid/Ask 07:32:09 23/05/2024 pm IST
11.28 EUR / 11.39 EUR +5.84% Intraday chart for FAKTOR-OPTIONSSCHEIN - HALEON
Current month-28.41%
1 month-18.62%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
23/24/23 12.04 +12.42%
22/24/22 10.71 -10.53%
21/24/21 11.97 -3.86%
20/24/20 12.45 +7.05%
17/24/17 11.63 -0.85%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 01:26 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MG0J13
ISINDE000MG0J133
Date issued 20/03/2024
Strike 298.4 p
Maturity Unlimited
Parity 0.03 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 17.19
Lowest since issue 10.35
Spread 0.11
Spread %0.93%

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.311 GBP
Average target price
3.62 GBP
Spread / Average Target
+9.33%
Consensus